JORDAN STEMER - MIRANDA: Open Payments
NPI 1861708323 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,055 in 229 payments from 27 companies in 2025. Trend: 2023 $3,790 · 2024 $4,890 · 2025 $5,055
Food & beverage: $4,339Consulting: $500Education: $215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $667 |
| UCB, Inc. | 22 | $602 |
| Journey Medical Corporation | 2 | $515 |
| Galderma Laboratories, L.P. | 30 | $512 |
| Janssen Biotech, Inc. | 15 | $472 |
| Lilly USA, LLC | 16 | $353 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $295 |
| PFIZER INC. | 18 | $270 |
| Novartis Pharmaceuticals Corporation | 8 | $232 |
| Incyte Corporation | 8 | $210 |
Products named: Bimzelx, SKYRIZI, TREMFYA, NEMLUVIO, EBGLYSS, OPZELURA, CIBINQO, DUPIXENT.
Industry payments across IN — which companies pay providers there.
